Blog / Archives
Reflation trade picks up after Auction
Auction Goes Well The Treasury sold $35 B of 5 Year Bonds at 2.32% higher than the last auction of 2.19% so analysts felt this was a good sign because it was the second strong auction in a row after...
Perfect Storm of Financial Distress from BIO
BIOblog for GEN BIO Super Session Weathering the Perfect Storm of Financial Distress Rod Raynovich 5/20/09 At the end of this session someone in the audience asked, ”You described the Perfect Storm...
Update on Biomarkers From BIO Conf
BIOblog for GEN Update on Biomarkers Rod Raynovich 5/19/09 In the October 1 issue of GEN I wrote a review of the impact of genomics in diagnostics and the potential of “companion diagnostics” or the...
Reflation trade kicks up
The reflation trade picked up the MO today with big winners among commodity and precious metal stocks. Dollar weakness,10 year treasuries hitting 3.2%, and China's appetite for raw materials and...
Swine Flu fear boost Biotechs
The U.S. Government declared an emergency Sunday and released 25% of Relenza and Tamiflu antiviral treatment courses for use by healthcare providers should cases escalate. Tamiflu was developed by...
Macro Reflation trade: Deflation risk persists
An April 14 story on Bloomberg said that the ECB may have to lower interest rates below 1.25% next month to counter the worse recession in six decades. And the FED continued its quantitative easing...
Q1 Biotechnology Update
The March rally improved the performance of the Life Science sector in Q1 but trailed gains in the technology sector. The S&P Healthcare Index lost 8.5% in Q1 compared to the S&P 500 loss of 11.7%....
Reflation trade: print print print to fight deflation
Another $1.1 Trillion to be thrown out by the FED with $300M to buy treasury securities and more purchases of mortgage backed securities and agency debt. Big rally in Treasury bonds.FED is market...
Big Rally in Biopharm coming off technical bottoms
Biotech and large cap pharmaceutical stocks rallied today overcoming fears of the Obama administration healthcare initiatives that created a bearish pall on the industry. The mood is reminiscent of...
Blockbuster mergers fail to lift Biotech stocks
Roche boosted its price to $95 to buy Genentech as expected and Merck will buy Schering Plough for a cash and stock deal valued at $41B including $10.50 in cash. M&A was one of the themes expected...